Breaking News Instant updates and real-time market news.

MRSN

Mersana Therapeutics

$1.45

(0.00%)

04:55
10/09/19
10/09
04:55
10/09/19
04:55

Mersana Therapeutics management to meet with SVB Leerink

Meetings to be held in San Francisco on October 7-8 and in San Diego on October 9 hosted by SVB Leerink.

  • 09

    Oct

MRSN Mersana Therapeutics
$1.45

(0.00%)

11/14/18
11/14/18
UPGRADE
Target $14

Outperform
Mersana Therapeutics upgraded to Outperform on valuation at Leerink
As previously reported, Leerink analyst Jonathan Chang upgraded Mersana Therapeutics to Outperform from Market Perform, with $14 price target. The analyst cited valuation as the stock is trading at historic lows. Chang notes that the company reported Q3 financial results and provided a pipeline update that was largely in-line with expectations, and points out that the next key catalysts for the stock will be initial XMT-1536 Phase I dose-escalation data in 1H19 and potential XMT-1522 Phase I update in mid-2019.
01/04/19
HCWC
01/04/19
NO CHANGE
Target $14
HCWC
Buy
Mersana's discontinuation of XMT-1522 'the right decision,' says H.C. Wainwright
After Mersana (MRSN) announced the discontinuation of its HER-2 targeted program XMT-1522, H.C. Wainwright analyst Debjit Chattopadhyay told investors in a research note that "this was the right decision" for the company, given the competitive landscape and the need to reevaluate the dose and schedule stemming from the partial clinical hold. Additionally, the analyst says that the discontinuation of XMT-1522 and clinical focus on XMT-1536 suggest cash and equivalents are sufficient to fund operations into 2020. The analyst maintains a Buy rating and $14 price target on Mersana.
03/11/19
JPMS
03/11/19
DOWNGRADE
JPMS
Underweight
Mersana Therapeutics downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jessica Fye downgraded Mersana Therapeutics to Underweight from Neutral without a price target. With the data for lead asset XMT-1536 at least a year away, the analyst expects the stock to underperform in the near term. Mersana shares reflect "substantial market skepticism already," but upcoming 2019 data releases may not be able to reverse that sentiment, Fye tells investors in a research note. Following the announcement to discontinue development of XMT-1522, the analyst believes there is now greater pressure on XMT-1536 to demonstrate success.
08/20/19
HCWC
08/20/19
NO CHANGE
HCWC
H.C. Wainwright says trial initiation at higher dosing 'bodes well' for Mersana
H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating and $7 price target on Mersana Therapeutics, noting that the expansion cohort dosing of XMT-1536 at 36 mg/m, which was higher than anticipated, "offers significant breathing room, and should clear the air on the safety profile."

TODAY'S FREE FLY STORIES

FLXN

Flexion

$13.37

0.125 (0.94%)

08:47
10/14/19
10/14
08:47
10/14/19
08:47
Recommendations
Flexion analyst commentary  »

Benchmark still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

, USAT

USA Technologies

$0.00

(0.00%)

08:45
10/14/19
10/14
08:45
10/14/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

USAT

USA Technologies

$0.00

(0.00%)

BYND

Beyond Meat

$131.40

-4.6 (-3.38%)

CGC

Canopy Growth

$19.42

-1.005 (-4.92%)

CHK

Chesapeake

$1.38

0.09 (6.98%)

PZZA

Papa John's

$53.16

0.32 (0.61%)

NVAX

Novavax

$4.57

0.11 (2.47%)

DXJ

WisdomTree Japan Hedged Equity Fund

$51.12

1.1 (2.20%)

PTON

Peloton

$22.40

-0.755 (-3.26%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Recommendations
Netflix analyst commentary  »

RBC Capital sees Q3 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

AKTX

Akari Therapeutics

$1.81

-0.03 (-1.63%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Hot Stocks
Akari Therapeutics announces new data from ongoing Phase I/II AKC trial »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:41
10/14/19
10/14
08:41
10/14/19
08:41
Hot Stocks
Parsley Energy sees Jagged Peak Energy deal immediately accretive on key metrics »

Key Transaction…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

08:40
10/14/19
10/14
08:40
10/14/19
08:40
Initiation
Envista initiated  »

Envista initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVST

Envista

$27.87

-1.2 (-4.13%)

, DHR

Danaher

$138.78

0.1 (0.07%)

08:38
10/14/19
10/14
08:38
10/14/19
08:38
Initiation
Envista, Danaher initiated  »

Envista initiated with an…

NVST

Envista

$27.87

-1.2 (-4.13%)

DHR

Danaher

$138.78

0.1 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

KALV

KalVista

$11.00

0.27 (2.52%)

, RGNX

Regenxbio

$39.53

0.65 (1.67%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Recommendations
KalVista, Regenxbio, Kala Pharmaceuticals, Kodiak Sciences, Regeneron, Aerie Pharmaceuticals, Applied Genetic, Aldeyra, Adverum Biotechnologies, Clearside Biomedical, Ocugen analyst commentary  »

Ophthalmic therapies…

KALV

KalVista

$11.00

0.27 (2.52%)

RGNX

Regenxbio

$39.53

0.65 (1.67%)

KALA

Kala Pharmaceuticals

$3.45

-0.15 (-4.17%)

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

REGN

Regeneron

$301.02

2.56 (0.86%)

AERI

Aerie Pharmaceuticals

$20.15

2.45 (13.84%)

AGTC

Applied Genetic

$3.10

-0.08 (-2.52%)

ALDX

Aldeyra

$5.16

-0.09 (-1.71%)

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

CLSD

Clearside Biomedical

$0.76

0.0326 (4.47%)

OCGN

Ocugen

$1.51

-0.07 (-4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 24

    Oct

  • 05

    Nov

  • 06

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Hot Stocks
Parsley Energy, Jagged Peak Energy boards 'unanimously' approve merger »

The boards of directors…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HPE

HP Enterprise

$14.35

0.24 (1.70%)

08:36
10/14/19
10/14
08:36
10/14/19
08:36
Upgrade
HP Enterprise rating change  »

HP Enterprise upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

, BABA

Alibaba

$172.97

6.925 (4.17%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Genius Brands, Alibaba partner to co-produce animated children's series »

Genius Brands…

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

BABA

Alibaba

$172.97

6.925 (4.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Parsley Energy sees FY20 CapEx $1.6B-$1.9B »

Parsley (PE) remains…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CUB

Cubic

$68.86

0.58 (0.85%)

, SAIC

SAIC

$84.56

1.05 (1.26%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Cubic appoints Hilary Hageman as general counsel »

Cubic (CUB) announced the…

CUB

Cubic

$68.86

0.58 (0.85%)

SAIC

SAIC

$84.56

1.05 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

BLPH

Bellerophon

$0.45

-0.0104 (-2.26%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Bellerophon to present new data from Cohort 1 of Phase 2/3 study of INOpulse »

lpBellerophon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Parsley Energy sees Q3 net oil production 91.2-91.7 MBo per day »

For the third quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AXAS

Abraxas Petroleum

$0.37

0.0069 (1.89%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Earnings
Abraxas Petroleum broadens engagement with Petrie Partners »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:32
10/14/19
10/14
08:32
10/14/19
08:32
Hot Stocks
Parsley Energy to acquire Jagged Peak Energy in $2.27B all-stock transaction »

Parsley Energy (PE) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

RARE

Ultragenyx

$42.77

1.08 (2.59%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Hot Stocks
Ultragenyx announces FDA acceptance of NDA for UX007 »

Ultragenyx Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$260.46

8.86 (3.52%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Recommendations
ASML analyst commentary  »

ASML price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:30
10/14/19
10/14
08:30
10/14/19
08:30
Hot Stocks
Breaking Hot Stocks news story on Parsley Energy, Jagged Peak Energy »

Parsley Energy acquires…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DRYS

DryShips

$5.25

(0.00%)

, NCI

Navigant Consulting

$28.00

(0.00%)

08:30
10/14/19
10/14
08:30
10/14/19
08:30
Options
Four option delistings on October 14th »

Option delistings…

DRYS

DryShips

$5.25

(0.00%)

NCI

Navigant Consulting

$28.00

(0.00%)

TYPE

Monotype Imaging

$19.85

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$42.40

0.15 (0.36%)

08:29
10/14/19
10/14
08:29
10/14/19
08:29
Initiation
Omega Healthcare initiated  »

Omega Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:25
10/14/19
10/14
08:25
10/14/19
08:25
Recommendations
Netflix analyst commentary  »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
10/14/19
10/14
08:24
10/14/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
10/14/19
10/14
08:24
10/14/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.